Dynavax Technologies | Netto Inntekt

Net Income Endring Dato
AbbVie USD 1.37B 547M 2024-03
Adma Biologics USD 17.81M 35.45M 2024-03
Amgen USD -113000000 880M 2024-03
AstraZeneca USD 2.18B 1.22B 2024-03
Biogen USD 393.4M 143.7M 2024-03
BioMarin Pharmaceutical USD 88.66M 68.29M 2024-03
Bristol-Myers Squibb USD -11911000000 13.67B 2024-03
Dynavax Technologies USD -8721000 8.94M 2024-03
Gilead Sciences USD -4170000000 5.6B 2024-03
Glaxosmithkline GBP 1.05B 696M 2024-03
Merck USD 4.76B 5.99B 2024-03
Neurocrine Biosciences USD 43.4M 39.7M 2024-03
Novartis USD 2.69B 5.79B 2024-03
Pfizer USD 3.12B 6.48B 2024-03
Regeneron Pharmaceuticals USD 722M 437.6M 2024-03
Roche Holding CHF 7.14B 3.25B 2023-06
Sarepta Therapeutics USD 36.12M 77.06M 2024-03
TG Therapeutics USD -10707000 3.71M 2024-03
Vertex Pharmaceuticals USD 1.1B 64.3M 2024-03



Dynavax Technologies Netto Inntekt - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.